Terms: = Pancreatic cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Treatment
470 results:
1. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
2. Lymph node metastases are more frequent in paediatric appendiceal NET ≥1.5 cm but without impact on outcome - Data from the German met studies.
Kuhlen M; Kunstreich M; Pape UF; Seitz G; Lessel L; Vokuhl C; Frühwald MC; Vorwerk P; Redlich A
Eur J Surg Oncol; 2024 Apr; 50(4):108051. PubMed ID: 38430702
[TBL] [Abstract] [Full Text] [Related]
3. Are We There Yet? - Alternating Chemotherapy Regimens in pancreatic cancer.
Sahai V; Benson AB
NEJM Evid; 2024 Feb; 3(2):EVIDe2300341. PubMed ID: 38320497
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Wu JY; Wu JY; Fu YK; Ou XY; Li SQ; Zhang ZB; Zhou JY; Li B; Wang SJ; Chen YF; Yan ML
Ann Surg Oncol; 2024 May; 31(5):3073-3083. PubMed ID: 38316732
[TBL] [Abstract] [Full Text] [Related]
5. KIF20B and met, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
[TBL] [Abstract] [Full Text] [Related]
6. Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis.
Xue K; Huang X; Zhao P; Zhang Y; Tian B
Int J Surg; 2023 Dec; 109(12):4309-4321. PubMed ID: 38259002
[TBL] [Abstract] [Full Text] [Related]
7. Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.
Wang K; Xiang YJ; Yu HM; Cheng YQ; Liu ZH; Qin YY; Shi J; Guo WX; Lu CD; Zheng YX; Zhou FG; Yan ML; Zhou HK; Liang C; Zhang F; Wei WJ; Lau WY; Li JJ; Liu YF; Cheng SQ
Nat Med; 2024 Mar; 30(3):708-715. PubMed ID: 38242982
[TBL] [Abstract] [Full Text] [Related]
8. Survival outcomes after caudate lobectomy for hepatocellular carcinoma: systematic review and meta-analysis.
Al-Ameri AAM; Zheng S
ANZ J Surg; 2024 Mar; 94(3):335-341. PubMed ID: 38193603
[TBL] [Abstract] [Full Text] [Related]
9. The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies.
Shen Y; Xia J; Yi C; Li T; Wang P; Dai L; Shi J; Wang K; Sun C; Ye H
Eur J Nutr; 2024 Apr; 63(3):653-672. PubMed ID: 38170272
[TBL] [Abstract] [Full Text] [Related]
10. Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer.
Dong W; Zhao H; Xiao S; Zheng L; Fan T; Wang L; Zhang H; Hu Y; Yang J; Wang T; Xiao W
Front Immunol; 2023; 14():1263633. PubMed ID: 38149248
[TBL] [Abstract] [Full Text] [Related]
11. Prioritization of Fluorescence In Situ Hybridization (FISH) Probes for Differentiating Primary Sites of Neuroendocrine Tumors with Machine Learning.
Pietan L; Vaughn H; Howe JR; Bellizzi AM; Smith BJ; Darbro B; Braun T; Casavant T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139230
[TBL] [Abstract] [Full Text] [Related]
12. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
[TBL] [Abstract] [Full Text] [Related]
13. Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial metNET2.
Pusceddu S; Corti F; Prinzi N; Nichetti F; Ljevar S; Busico A; Cascella T; Leporati R; Oldani S; Pircher CC; Coppa J; Resi V; Milione M; Maccauro M; Miceli R; Tamborini E; Perrone F; Spreafico C; Niger M; Morano F; Pietrantonio F; Seregni E; Mariani L; Mazzaferro V; Di Liberti G; Fucà G; de Braud F; Vernieri C
J Hematol Oncol; 2023 Dec; 16(1):119. PubMed ID: 38098114
[TBL] [Abstract] [Full Text] [Related]
14. A multicenter retrospective analysis: Factors influencing hepatic adverse events induced by immunotherapy in advanced liver cancer.
Zou R; Hao Y; Wang Y; Yan F; Peng X; Huang Z; Chen G
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1918. PubMed ID: 38073600
[TBL] [Abstract] [Full Text] [Related]
15. Disparities in pancreatic cancer Outcomes in the Disaggregated Asian American Population.
Kooragayala K; Lou J; Dibato J; Hong YK
Ann Surg Oncol; 2024 Feb; 31(2):1298-1309. PubMed ID: 37880517
[TBL] [Abstract] [Full Text] [Related]
16. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
[TBL] [Abstract] [Full Text] [Related]
17. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
Surgery; 2024 Mar; 175(3):695-703. PubMed ID: 37863686
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathological and prognostic values of met expression in pancreatic adenocarcinoma based on bioinformatics analysis.
Yao Y; Zhan R; Gong C; Lv J; Lu X
Medicine (Baltimore); 2023 Oct; 102(41):e34656. PubMed ID: 37832054
[TBL] [Abstract] [Full Text] [Related]
19. Clinical and genomic characterisation of early-onset pancreatic cancer.
Castet F; Fabregat-Franco C; Castillo G; Navarro V; Sierra A; Acosta DA; López-Valbuena D; Dienstmann R; Tabernero J; Vivancos A; Tian TV; Macarulla T
Eur J Cancer; 2023 Nov; 194():113338. PubMed ID: 37793216
[TBL] [Abstract] [Full Text] [Related]
20. Systemic Therapy for Tumor Control in metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
Del Rivero J; Perez K; Kennedy EB; Mittra ES; Vijayvergia N; Arshad J; Basu S; Chauhan A; Dasari AN; Bellizzi AM; Gangi A; Grady E; Howe JR; Ivanidze J; Lewis M; Mailman J; Raj N; Soares HP; Soulen MC; White SB; Chan JA; Kunz PL; Singh S; Halfdanarson TR; Strosberg JR; Bergsland EK
J Clin Oncol; 2023 Nov; 41(32):5049-5067. PubMed ID: 37774329
[TBL] [Abstract] [Full Text] [Related]
[Next]
